Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fibrauretinum is a plant-derived small-molecule alkaloid preparation, corresponding to the traditional Chinese medicine component 黄藤素 (Fibrauretin), extracted from Fibraurea species and related Menispermaceae plants, and used in China as a modern TCM product. It exhibits broad antimicrobial and immunomodulatory activity, with reported inhibition of bacteria, fungi and viruses and enhancement of nonspecific immune functions in animal models, and has been developed as a pharmaceutical product (including suppositories) for infectious and inflammatory conditions rather than a single well-defined molecular target. Its precise molecular mechanism of action and primary biological target are not well characterized in the contemporary pharmacology literature.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fibrauretinum.